Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Canadian Treatment Action Council (CTAC) is a national non-governmental organization in Canada dedicated to promoting access to treatment, care, and support for individuals living with HIV and Hepatitis C. Founded in 1996, the organization operates at the intersection of community advocacy and health policy, working to ensure that healthcare systems and drug approval processes are responsive to patient needs. CTAC engages in policy research, capacity building, and multi-stakeholder consultations with government agencies, researchers, and the pharmaceutical industry. By addressing barriers to treatment equity and monitoring the drug pipeline, CTAC aims to improve health outcomes and the quality of life for affected populations across Canada.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canadian Treatment Action Council.